Intelligence · Clinical pipeline
Autoimmune & immunology R&D Pipeline
Autoimmune, rheumatology, and immunology biologics in clinical development.
Quick answer
Autoimmune & immunology: NovaPharmaNews indexes 985 autoimmune & immunology clinical pipeline programs from ClinicalTrials.gov with phase, modality, NCT identifiers, and sponsor company links. Autoimmune, rheumatology, and immunology biologics in clinical development.
Top sponsors
- Takeda 87 programs
- Chinese Academy of 58 programs
- Anaxis Pharma 52 programs
- Janssen-Cilag International N.V 34 programs
- Novartis India 32 programs
- First People's Hospital 23 programs
- Lakefront Biotherapeutics NV 22 programs
- AbbVie 21 programs
- AbbVie Deutschland GmbH 20 programs
- Regeneron UK 20 programs
- HOFFMANN-LA ROCHE 19 programs
- Pacira Ireland 18 programs
Pipeline programs
-
Re-JIA
Istituto Gentili S.r.l.
Juvenile idiopathic arthritis
1 trial -
Remsima 100 mg powder for concentrate for solution for infusion
Disc Medicine
Crohn's Disease
1 trial -
Rosuvastatin
Hospital Authority, Hong Kong
Systemic Lupus Erythematosus
1 trial -
Sarilumab
Regeneron UK Limited
Polymyalgia Rheumatica
1 trial -
Sarilumab
Regeneron UK Limited
Rheumatoid Arthritis
8 trials -
Saussurea Involucrata Liquid Tonic
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Postpartum Rheumatism
1 trial -
Spesolimab
Boehringer Ingelheim
Generalized Pustular Psoriasis
3 trials -
TARGET2020
Sana Biotechnology
Systemic Lupus Erythematosus
1 trial -
Tetanusvaccin, suspensie voor injectie 40 IE
Disc Medicine
Systemic sclerosis, Systemic lupus erythematosus, Rheumatoid arthritis
1 trial -
Tofacitinib with methotrexate
Pfizer
Rhematoid Arthritis
1 trial -
Treatment Algorithm A
Takeda
Colitis, Ulcerative
1 trial -
Triamcinolone acetonide-Ketorolac-Ropivacaine
United Therapeutics Europe Ltd
Osteoarthritis, Knee
1 trial -
Triptergium Wilfordii
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Psoriasis Vulgaris
1 trial -
Vedolizumab
Takeda
Crohn's Disease
6 trials -
Vedolizumab
Takeda
Crohn Disease
4 trials -
Vedolizumab
Second Affiliated Hospital of Soochow University
Ulcerative Colitis (UC)
1 trial -
Vedolizumab
Takeda
Moderately to Severely Active Crohn's Disease
1 trial -
Vedolizumab 300 mg
Takeda
Colitis, Ulcerative
1 trial -
Vedolizumab IV
Takeda
Colitis, Ulcerative
1 trial -
Vyvgart 20 mg/mL concentrate for solution for infusion
The George Institute
Patients affected by generalized myasthenia gravis
1 trial -
Wangbi granules
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Rheumatoid Arthritis
1 trial -
XELJANZ 11 mg prolonged-release tablets
Disc Medicine
Rheumatoid arthritis or psoriatic arthritis according to respectively 2010 criteria or CASPAR criteria
1 trial -
Yuflyma solution for injection in pre-filled pen for Rheumatoid arthritis
Lacuna Pharma Pty Ltd
Rheumatoid arthritis
1 trial -
Zushima plaster with high dose
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Osteoarthritis
1 trial -
bimekizumab
Lacuna Pharma Pty Ltd
Moderate to Severe Plaque Psoriasis, Psoriatic arthritis
1 trial -
biologics treatment
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Psoriasis
1 trial -
fecal microbiota transplantation
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Ulcerative Colitis
1 trial -
hyaluronic Acid + platelet-rich plasma
Regeneron Ireland Designated Activity Company (DAC)
Knee Osteoarthritis
1 trial -
hylan G-F 20
United Therapeutics Europe Ltd
Osteoarthritis, Knee
1 trial -
large protein molecule
HALOZYME THERAPEUTICS, INC.
Rheumatoid Arthritis
1 trial -
methotrexate (MTX)
AbbVie
Psoriatic Arthritis
1 trial -
tacrolimus
Chinese University of Hong Kong
Lupus Nephritis
1 trial -
A+ HA(tm)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Knee Osteoarthritis
2 trials -
Bundle Group 1 with Nutrilite Lifestyle
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Osteoarthritis
1 trial -
Celebrex
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Knee Osteoarthritis
1 trial -
Cyclophosphamide
Ultragenyx UK Limited
Systemic Lupus Erythematosus
1 trial -
Du-Huo-Ji-Sheng-Tang (DHJST)
Chinese University of Hong Kong
Knee Osteoarthritis
1 trial -
EVM18001 Injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
System Lupus Erythematosus(SLE)
1 trial -
Efgartigimod + Telitacicept (1-week interval) group
The First People's Hospital of Lianyungang
Myasthenia Gravis
1 trial -
Estrogen-bazedoxifene
United Therapeutics Europe Ltd
Hand Osteoarthritis
1 trial -
Exclusive Enteral Nutrition Therapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Crohn's Disease
1 trial -
Group A
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Crohn Disease
1 trial -
Guselkumab
BRIGHT MINDS BIOSCIENCES INC.
Psoriasis Vulgaris
1 trial -
Human umbilical cord mesenchymal stem cells
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Knee Osteoarthritis
1 trial -
Huoluo Pills
Universal Integrated
Rheumatoid Arthritis
1 trial -
IMIQUIMOD cream 50mg/g
BRIGHT MINDS BIOSCIENCES INC.
Cutaneous Lupus Erythematosus
1 trial -
Ivarmacitinib tablet
The First People's Hospital of Lianyungang
Polymyalgia Rheumatics (PMR)
1 trial -
Ixekizumab+Jueyin Granules
Universal Integrated
Plaque Psoriasis
1 trial
Frequently asked questions
How many autoimmune & immunology pipeline programs are tracked?
985 programs match this therapeutic area based on indication text, program name, and registry metadata.
Where does pipeline data come from?
ClinicalTrials.gov records linked to NovaPharmaNews company profiles. Verify on ClinicalTrials.gov before investment decisions.